In drug development, it is essential to determine whether the pharmacokinetic parameters of a new drug candidate, for a given dose range, are linear or nonlinear. While it is impossible to establish a complete PK profile for all doses, prediction of drug exposure in a certain dose range can be easily made if the compound possesses the property of dose proportionality(DP). This property is also called dose-independent and is related to linear PK.
In the analysis of dose proportionality, by administering different doses of drugs, testing the plasma drug concentration of the compound in the animal body, and calculating the drug exposure, the relationship between the administered dose of the small molecule drug and the body exposure can be calculated.
Single Ascending Dose Proportionality Study Protocol
| Species | Mouse, rat, dog, monkey, cat, rabbit, guinea pig |
| Dosing route | P.O., I.V., I.M.; I. P., etc |
| Groups | Multiple groups with different dosages |
| Dosing frequency | Single Ascending Dose Study |
| Number of animals | 3 per group |
| Time points | 5min, 15 min，30 min, 1 hr, 2 hr, 4 hr, 8 hr, 24 hr （other time points can be chosen） |
| Analysis method | LC-MS/MS , standard curve |
| Data analysis | WinNonlin |
| Turn Around Time | 5 working days |
Send Request
Other bioanalysis services in Vivo DMPK:
- Single Dose PK
- Multiple Ascending Dose Study
- Blood-Brain Barrier Permeability Study
- Tissue Distribution
- Toxicokinetics Study
Related Articles: